The Role of Neutrophil-to-Lymphocyte Ratio in Advanced EGFR-Mutant NSCLC Patients Treated with First-Line Osimertinib

Chen KC, Huang YH, Hsu KH, Tseng JS, Chang GC, Yang TY

OncoTargets and Therapy 2023, 16:317-326

Published Date: 17 May 2023